Table 1.

Definition of GVL and noGVL

GVLnoGVL
Relative decrease of host chimerism by ≥50% (compared with previous time point) or absolute decrease by ≥1.00%
or
Stable* host chimerism after previous GVL
and/or
Conversion of MRD from positive to negative or MRD level decrease by ≥10-fold
and
no cytologic or extramedullary relapse/progressive disease 
Stable*/increased host chimerism (compared with previous time point) and/or MRD persistence or MRD level decrease by <10-fold and/or molecular, cytologic, or extramedullary relapse/progressive disease 
GVLnoGVL
Relative decrease of host chimerism by ≥50% (compared with previous time point) or absolute decrease by ≥1.00%
or
Stable* host chimerism after previous GVL
and/or
Conversion of MRD from positive to negative or MRD level decrease by ≥10-fold
and
no cytologic or extramedullary relapse/progressive disease 
Stable*/increased host chimerism (compared with previous time point) and/or MRD persistence or MRD level decrease by <10-fold and/or molecular, cytologic, or extramedullary relapse/progressive disease 
*

Stable host chimerism was defined as <50% decrease or increase of host chimerism compared with previous time point.

Close Modal

or Create an Account

Close Modal
Close Modal